Pay in 4 interest-free payments of $6.30 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
LaVoie HA, King SR
It belongs to the family of GLP-1 receptor agonists (GLP-1-RA), initially used for the treatment of people with obesity-associated type 2 diabetes and later for people with obesity without diabetes, commercialised for use in obesity under the name Wegovy
This informs your medication choice, starting dose, and any contraindications we need to know about before we prescribe
A lot of compounded drugs come in units, Simonetti says
Gastrointestinal effects typically occur during the initial weeks of treatment or following dose escalation, with many improving as the body adjusts to the medication
Revised Cochrane risk of bias tool for randomized trials (RoB 2.0) 2016
US$ 22.31
US$ 22.98
US$ 21.27
US$ 26.88
